Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PDX Pharmaceuticals logo — Delivery of Next-Gen Combination and Immunotherapies on Nano...

PDX Pharmaceuticals

Delivery of Next-Gen Combination and Immunotherapies on Nanotechnology Platform.

Founded 2010 United States Portland, United States 9 employees Series A Total: $1.55M Biotechnology, Health Care +1

General Information

Company Name PDX Pharmaceuticals
Founded Year 2010
Location United States Portland, United States
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with PDX Pharmaceuticals. To contact PDX Pharmaceuticals, visit pdxpharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PDX Pharmaceuticals compare?

A PDF of PDX Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PDX Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PDX Pharmaceuticals

PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways together to achieve synergistic clinical benefit. Our therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production. Our pipelines are patented AIRISE (Augmenting Immune Responses and Inhibiting the Suppressive Environment of Tumors) and ARAC (Antigen Release Agent and Checkpoint Inhibitor) pipelines that generate anti-tumor immunity when given locally (AIRISE) or systemically (ARAC) by relying on patient' s own tumor in situ as the source of antigens.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $1.55M 1
Kuni Foundation
Kuni Foundation
27 Nov 2019

PDX Pharmaceuticals Alternatives & Competitors

PDX Pharmaceuticals vs
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. United States

Targeting intractable immune pathways in the tumor microenvironment

Series A
8 employees
Biotechnology, Pharmaceutical

FAQ About PDX Pharmaceuticals

Delivery of Next-Gen Combination and Immunotherapies on Nanotechnology Platform.
PDX Pharmaceuticals was founded in 2010.
PDX Pharmaceuticals is headquartered in Portland, United States.
PDX Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical.
PDX Pharmaceuticals has approximately 9 employees.
PDX Pharmaceuticals has completed 1 funding round, raising a total of $1.55M. The latest funding stage is Series A.
Top alternatives and competitors to PDX Pharmaceuticals include Actym Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PDX Pharmaceuticals and Actym Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PDX Pharmaceuticals, https://bouncewatch.com/company/pdx-pharmaceuticals, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout